Linda Finkel

Linda Finkel leads at the intersection of strategic vision, technology and operational discipline to transform startup and legacy companies in the health tech space where she has spent the last 15 years. Linda has more than 25 years starting, growing and running successful companies, both public and private.

As the CEO of OutcomesAI, she is working to redefine nursing through AI-enabled care delivery. OutcomesAI’s proprietary AI engine, Glia, combines voice agents, productivity tools, and licensed nurses to automate routine patient interactions, scale triage and virtual care programs, and deliver safe, cost-effective care. OutcomesAI partners with health systems, virtual care providers, and pharmaceutical companies to expand nursing capacity, improve patient access, and reduce costs.

Prior to OutcomesAI, Linda served as CEO of AVIA Health, a digital transformation partner to 53 leading US health systems with 500+ hospitals, building digital roadmaps and accelerating their successful execution. There, she also oversaw the launch of AVIA Marketplace which reached another 67,000 healthcare leaders and thousands of digital health companies. As employee #5, she grew AVIA to be a $20M enterprise—and a leader in the digital health space.

Prior AVIA, she served as Chief Operating Officer, R1’s (then NASDAQ: RCM) population health business with responsibility for all core elements of service launch and delivery with teams across the US and India.

Linda held several executive leadership roles prior to entering healthcare in 2010. These include Co-Head and Chief Operating Officer, Bowne Business Solutions, division of Bowne & Co (NYSE:BNE) where she led the business to market leadership with revenue of $300 million and 3,000 employees in the US, UK, Hong Kong and Singapore. She also served as President of Donnelley Business Services which she grew to be the leading business services provider to top-tier financial institutions and professional service firms. Linda also served as a founding leader of Donnelley Enterprise Solutions and helped take the company public (NASDAQ:DESI).

She is also an active member of The Breakthrough Board of UChicago Medicine, The Chicago Network, Cambridge Health Network and The Economic Club of Chicago. She has served on the board of the Foundation for Sarcoidosis Research and as a Trustee of Chicago City Day School. She is obsessed with international travel, learning and any sport with a racquet.

Linda holds an MBA from Harvard Business School and a BA from Stanford University.